These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 513481)

  • 61. Sodium restriction corrects hyperfiltration of diabetes.
    Bank N; Lahorra G; Aynedjian HS; Wilkes BM
    Am J Physiol; 1988 May; 254(5 Pt 2):F668-76. PubMed ID: 3284388
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glomerular and renal hemodynamics during converting enzyme inhibition (SQ20,881) in the dog.
    Navar LG; LaGrange RA; Bell PD; Thomas CE; Ploth DW
    Hypertension; 1979; 1(4):371-7. PubMed ID: 396240
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of the angiotensin antagonist saralasin on blood pressure and hemodynamics in patients with terminal renal insufficiency].
    Tuma J; Beckerhoff R; Záruba K; Furrer J; Vetter W
    Schweiz Med Wochenschr; 1977 May; 107(20):704-9. PubMed ID: 867013
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effect of saralasin infusion on glomerular filtration rate and sodium excretion in hypertensive patients (author's transl)].
    de Franca Borges H; da Silva Saragoça MA; Kater CE; Ribeiro AB; Ajzen H; Ramos OL
    Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):293-302. PubMed ID: 531273
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Haemodynamic response to converting enzyme inhibitor and saralasin in salt-depleted dogs; relation to plasma renin activity [proceedings].
    Conway J; Hatton R; Keddie J
    Br J Pharmacol; 1978 Mar; 62(3):448P. PubMed ID: 205299
    [No Abstract]   [Full Text] [Related]  

  • 66. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Angiotensin in the hemodynamic response to chronic nephron obstruction.
    Carmines PK; Tanner GA
    Am J Physiol; 1983 Jul; 245(1):F75-82. PubMed ID: 6346901
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of the ability of two angiotensin II receptor blocking drugs, 1-Sar; 8-Ala angiotensin II and 1-Sar, 8-Ile angiotensin II, to modify the regulation of glomerular filtration rate in the cat.
    Johns EJ
    Br J Pharmacol; 1980; 71(2):499-506. PubMed ID: 7470759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Studies on the mechanism of reduction in glomerular filtration rate after benzolamide.
    Tucker BJ; Blantz RC
    Pflugers Arch; 1980 Dec; 388(3):211-6. PubMed ID: 7193847
    [No Abstract]   [Full Text] [Related]  

  • 70. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Use of angiotensin antagonists in experimental and human renovascular hypertension.
    Maxwell MH
    Adv Nephrol Necker Hosp; 1979; 8():297-319. PubMed ID: 115245
    [No Abstract]   [Full Text] [Related]  

  • 72. Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease.
    Brod J; Bahlmann J; Cachovan M; Hubrich W; Pretschner D
    Nephron; 1980; 25(4):167-72. PubMed ID: 6990284
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Angiotensin II in adrenergic-induced alterations in glomerular hemodynamics.
    Pelayo JC; Ziegler MG; Blantz RC
    Am J Physiol; 1984 Nov; 247(5 Pt 2):F799-807. PubMed ID: 6093592
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
    Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM
    Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Saralasin and prediction of the surgical result in renovascular arterial hypertension].
    Mimran A; Deschodt G; Fourcade J; Barjon P
    Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():16-21. PubMed ID: 119507
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Glomerular hemodynamics in moderate Goldblatt hypertension in the rat.
    Steiner RW; Tucker BJ; Gushwa LC; Gifford J; Wilson CB; Blantz RC
    Hypertension; 1982; 4(1):51-7. PubMed ID: 7061129
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension.
    Gavras H; Flessas A; Ryan TJ; Brunner HR; Faxon DP; Gavras I
    JAMA; 1977 Aug; 238(8):880-2. PubMed ID: 577978
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor.
    Thurston H; Swales JD
    Circ Res; 1978 May; 42(5):588-92. PubMed ID: 639180
    [No Abstract]   [Full Text] [Related]  

  • 79. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I; Rosenthal J
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
    [No Abstract]   [Full Text] [Related]  

  • 80. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
    Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.